| 摘要 |
<p>Novel compounds of the formula: <IMAGE> (I) and the pharmaceutically acceptable acid addition salts thereof, wherein R1, R2, R3 and R4 are each independently hydrogen, hydroxy, lower alkyl, lower alkoxy or halo; R is hydrogen or lower alkyl; and A is selected from the group consisting of: 2-(benzodioxan-2-yl)-2-hydroxyethyl; omega -(benzodioxan-2-yl)-alkyl (1-4); 3-(aryloxy)-2-hydroxypropyl, wherein aryloxy is phenyloxy optionally substituted by 1-3 moieties selected from the group consisting of lower alkyl, lower alkoxy, halo, alkylsulfamido, lower alkoxycarbonyl, cyano and trifluoromethyl; omega -arylalkyl (1-4), wherein aryl is phenyl optionally substituted by 1-3 moieties selected from the group consisting of lower alkyl, lower alkoxy, halo, alkylsulfamido, lower alkoxycarbonyl, cyano and trifluoromethyl; omega -aryl- omega -oxoalkyl (1-4), wherein aryl is as herein defined; omega -aryl- omega -hydroxyalkyl (1-4), wherein aryl is as herein defined; and omega -arylalkyl (1-4), wherein aryl is as herein defined, are useful as antihypertensives.</p> |
